193 related articles for article (PubMed ID: 29066719)
21. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
Covell DG
PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
[TBL] [Abstract][Full Text] [Related]
22. Stress granule-associated protein G3BP2 regulates breast tumor initiation.
Gupta N; Badeaux M; Liu Y; Naxerova K; Sgroi D; Munn LL; Jain RK; Garkavtsev I
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1033-1038. PubMed ID: 28096337
[TBL] [Abstract][Full Text] [Related]
23. Framework and resource for more than 11,000 gene-transcript-protein-reaction associations in human metabolism.
Ryu JY; Kim HU; Lee SY
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9740-E9749. PubMed ID: 29078384
[TBL] [Abstract][Full Text] [Related]
24. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
[TBL] [Abstract][Full Text] [Related]
25. Computational identification of multi-omic correlates of anticancer therapeutic response.
Stetson LC; Pearl T; Chen Y; Barnholtz-Sloan JS
BMC Genomics; 2014; 15 Suppl 7(Suppl 7):S2. PubMed ID: 25573145
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines.
Chhibber A; French CE; Yee SW; Gamazon ER; Theusch E; Qin X; Webb A; Papp AC; Wang A; Simmons CQ; Konkashbaev A; Chaudhry AS; Mitchel K; Stryke D; Ferrin TE; Weiss ST; Kroetz DL; Sadee W; Nickerson DA; Krauss RM; George AL; Schuetz EG; Medina MW; Cox NJ; Scherer SE; Giacomini KM; Brenner SE
Pharmacogenomics J; 2017 Mar; 17(2):137-145. PubMed ID: 26856248
[TBL] [Abstract][Full Text] [Related]
27. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy.
Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT
Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188
[TBL] [Abstract][Full Text] [Related]
28. Assessment of modelling strategies for drug response prediction in cell lines and xenografts.
Kurilov R; Haibe-Kains B; Brors B
Sci Rep; 2020 Feb; 10(1):2849. PubMed ID: 32071383
[TBL] [Abstract][Full Text] [Related]
29. Unveiling novel targets of paclitaxel resistance by single molecule long-read RNA sequencing in breast cancer.
Lian B; Hu X; Shao ZM
Sci Rep; 2019 Apr; 9(1):6032. PubMed ID: 30988345
[TBL] [Abstract][Full Text] [Related]
30. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
31. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
32. Long-read sequencing uncovers a complex transcriptome topology in varicella zoster virus.
Prazsák I; Moldován N; Balázs Z; Tombácz D; Megyeri K; Szűcs A; Csabai Z; Boldogkői Z
BMC Genomics; 2018 Dec; 19(1):873. PubMed ID: 30514211
[TBL] [Abstract][Full Text] [Related]
33. Exploiting single-cell RNA sequencing data to link alternative splicing and cancer heterogeneity: A computational approach.
Manipur I; Granata I; Guarracino MR
Int J Biochem Cell Biol; 2019 Mar; 108():51-60. PubMed ID: 30633986
[TBL] [Abstract][Full Text] [Related]
34. Bayesian nonparametric discovery of isoforms and individual specific quantification.
Aguiar D; Cheng LF; Dumitrascu B; Mordelet F; Pai AA; Engelhardt BE
Nat Commun; 2018 Apr; 9(1):1681. PubMed ID: 29703885
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cells.
Liu L; Shi H; Liu Y; Anderson A; Peterson J; Greger J; Martin AM; Gilmer TM
Mol Cancer Ther; 2011 Mar; 10(3):518-30. PubMed ID: 21252284
[TBL] [Abstract][Full Text] [Related]
37. Optimal drug prediction from personal genomics profiles.
Sheng J; Li F; Wong ST
IEEE J Biomed Health Inform; 2015 Jul; 19(4):1264-70. PubMed ID: 25781964
[TBL] [Abstract][Full Text] [Related]
38. Studying Isoform-Specific mRNA Recruitment to Polyribosomes with Frac-seq.
Martinez-Nunez RT; Sanford JR
Methods Mol Biol; 2016; 1358():99-108. PubMed ID: 26463379
[TBL] [Abstract][Full Text] [Related]
39. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
Lu GY; Huang SM; Liu ST; Liu PY; Chou WY; Lin WS
Int J Biochem Cell Biol; 2014 Feb; 47():83-92. PubMed ID: 24333670
[TBL] [Abstract][Full Text] [Related]
40. Reproducible pharmacogenomic profiling of cancer cell line panels.
Haverty PM; Lin E; Tan J; Yu Y; Lam B; Lianoglou S; Neve RM; Martin S; Settleman J; Yauch RL; Bourgon R
Nature; 2016 May; 533(7603):333-7. PubMed ID: 27193678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
